178 related articles for article (PubMed ID: 18404997)
1. [Role of interleukin-9 in asthma and allergic reactions].
Renauld JC
Bull Mem Acad R Med Belg; 2007; 162(5-6):275-82; discussion 283-5. PubMed ID: 18404997
[TBL] [Abstract][Full Text] [Related]
2. Role of IL-9 in the pathophysiology of allergic diseases.
Soussi-Gounni A; Kontolemos M; Hamid Q
J Allergy Clin Immunol; 2001 Apr; 107(4):575-82. PubMed ID: 11295641
[TBL] [Abstract][Full Text] [Related]
3. [The role of interleukin-18 in the pathogenesis of bronchial asthma and other allergic diseases and in activation of basophils and mastocytes].
Kamiński M; Kłoda K; Pawlik A
Pneumonol Alergol Pol; 2008; 76(6):432-6. PubMed ID: 19173192
[TBL] [Abstract][Full Text] [Related]
4. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model.
Chen L; Overbergh L; Mathieu C; Chan LS
Clin Exp Allergy; 2008 Aug; 38(8):1367-80. PubMed ID: 18489026
[TBL] [Abstract][Full Text] [Related]
5. IL-13 as a therapeutic target for respiratory disease.
Kasaian MT; Miller DK
Biochem Pharmacol; 2008 Jul; 76(2):147-55. PubMed ID: 18502398
[TBL] [Abstract][Full Text] [Related]
6. YM-341619 suppresses the differentiation of spleen T cells into Th2 cells in vitro, eosinophilia, and airway hyperresponsiveness in rat allergic models.
Ohga K; Kuromitsu S; Takezawa R; Numazaki M; Ishikawa J; Nagashima S; Shimizu Y
Eur J Pharmacol; 2008 Aug; 590(1-3):409-16. PubMed ID: 18590722
[TBL] [Abstract][Full Text] [Related]
7. Restoration of T-box-containing protein expressed in T cells protects against allergen-induced asthma.
Park JW; Min HJ; Sohn JH; Kim JY; Hong JH; Sigrist KS; Glimcher LH; Hwang ES
J Allergy Clin Immunol; 2009 Feb; 123(2):479-85. PubMed ID: 19081613
[TBL] [Abstract][Full Text] [Related]
8. IL-5-induced airway eosinophilia--the key to asthma?
Hamelmann E; Gelfand EW
Immunol Rev; 2001 Feb; 179():182-91. PubMed ID: 11292022
[TBL] [Abstract][Full Text] [Related]
9. Lipopolysaccharide stimulation of dendritic cells induces interleukin-10 producing allergen-specific T cells in vitro but fails to prevent allergic airway disease.
Ahrens B; Freund T; Rha RD; Dittrich AM; Quarcoo D; Hutloff A; Hamelmann E
Exp Lung Res; 2009 May; 35(4):307-23. PubMed ID: 19415548
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-5 as a potential target for asthma treatment.
Wauwe JV
Drug News Perspect; 2000 May; 13(4):197-205. PubMed ID: 12937624
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms in allergic airway inflammation - lessons from studies in the mouse.
Shum BO; Rolph MS; Sewell WA
Expert Rev Mol Med; 2008 May; 10():e15. PubMed ID: 18503727
[TBL] [Abstract][Full Text] [Related]
12. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?
Robinson DS
J Allergy Clin Immunol; 2004 Jul; 114(1):58-65. PubMed ID: 15241345
[TBL] [Abstract][Full Text] [Related]
13. Mepacrine alleviates airway hyperresponsiveness and airway inflammation in a mouse model of asthma.
Ram A; Mabalirajan U; Singh SK; Singh VP; Ghosh B
Int Immunopharmacol; 2008 Jun; 8(6):893-9. PubMed ID: 18442795
[TBL] [Abstract][Full Text] [Related]
14. Involvement of IL-9 in the bronchial phenotype of patients with nasal polyposis.
Tsicopoulos A; Shimbara A; de Nadai P; Aldewachi O; Lamblin C; Lassalle P; Walls AF; Sénéchal S; Levitt RC; Darras J; Hamid Q; Wallaert B
J Allergy Clin Immunol; 2004 Mar; 113(3):462-9. PubMed ID: 15007348
[TBL] [Abstract][Full Text] [Related]
15. Preclinical safety and pharmacology of an anti-human interleukin-13 monoclonal antibody in normal macaques and in macaques with allergic asthma.
Martin PL; Fisher D; Glass W; O'Neil K; Das A; Martin EC; Li L
Int J Toxicol; 2008; 27(5):351-8. PubMed ID: 19037805
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic target validation of protein kinase C(PKC)-zeta for asthma using a mouse model.
Do JS; Park KS; Seo HJ; Kim JH; Hwang JK; Song EJ; Nam SY
Int J Mol Med; 2009 Apr; 23(4):561-6. PubMed ID: 19288034
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of interleukin-4, and -13 in the pathogenesis of allergic diseases].
Izuhara K
Rinsho Byori; 2001 Apr; 49(4):360-4. PubMed ID: 11391949
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma.
Liu X; Li M; Wu Y; Zhou Y; Zeng L; Huang T
Biochem Biophys Res Commun; 2009 Aug; 386(1):181-5. PubMed ID: 19508862
[TBL] [Abstract][Full Text] [Related]
19. Loss of classical transient receptor potential 6 channel reduces allergic airway response.
Sel S; Rost BR; Yildirim AO; Sel B; Kalwa H; Fehrenbach H; Renz H; Gudermann T; Dietrich A
Clin Exp Allergy; 2008 Sep; 38(9):1548-58. PubMed ID: 18631347
[TBL] [Abstract][Full Text] [Related]
20. Nonatopic allergen-independent mast cell activation in parasitized eosinophilic athymic rats.
Stoten A; Huntley J; Mistry H; Harper S; Bundick R; Brown A; Pritchard DI
Parasite Immunol; 2005 Dec; 27(12):431-8. PubMed ID: 16255741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
